Drug Policy
Medical Marijuana Uncertainty Persists Despite Patient Success Stories
Despite compelling patient testimonials about cannabis providing relief where traditional medications failed, medical professionals and lawmakers remain divided on medical marijuana's role in healthcare, creating ongoing uncertainty in the rapidly evolving cannabis industry.
Global Cannabis Leaders Converge in Southernmost City for Landmark Cultural Event
Major cannabis industry figures from across the globe are gathering in Ushuaia, Argentina for a groundbreaking cultural event that signals the maturation and globalization of the cannabis movement.
DEA Advances Psilocybin Rescheduling Petition to HHS for Scientific Review
The DEA's decision to forward psilocybin rescheduling for scientific review marks a significant regulatory shift that could expand medical access for veterans and palliative care patients while accelerating psychedelic research.
Supreme Court Decision Looms as Trump Administration Sends Mixed Signals on Marijuana Reform
The Supreme Court's potential involvement in marijuana reform creates uncertainty for the cannabis industry as the Trump administration provides conflicting signals on federal policy changes.
7-HOPE Alliance Defends Legality and Safety of 7-OH, Challenges Kratom Association Claims
The 7-HOPE Alliance asserts that 7-hydroxymitragynine is lawful and scientifically supported, countering claims by kratom associations while highlighting potential medical benefits and harm reduction value.
Anxiety Leads as Qualifying Condition in Pennsylvania's Medical Marijuana Program
A University of Pittsburgh study highlights anxiety as the top qualifying condition in Pennsylvania's medical marijuana program, signaling shifts in the industry and potential federal implications.